Literature DB >> 4108086

Variable mechanisms for low serum-complement in liver disease.

L D Petz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4108086     DOI: 10.1016/s0140-6736(71)90347-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.

Authors:  L H Perrin; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

2.  Acute hepatitis: significance of changes in complement components.

Authors:  J A Charlesworth; S Lawrence; P A Worsdall; L P Roy; C R Boughton
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

3.  Chronic active hepatitis and Graves' disease.

Authors:  W G Thompson; I R Hart
Journal:  Am J Dig Dis       Date:  1973-02

4.  Circulating conversion products of C3 in liver disease. Evidence for in vivo activation of the complement system.

Authors:  P Teisberg; E Gjone
Journal:  Clin Exp Immunol       Date:  1973-08       Impact factor: 4.330

5.  Relationship of serum alpha-fetoprotein to circulating immune complexes and complements in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.

Authors:  J F Tsai; J H Tsai; W Y Chang
Journal:  Gastroenterol Jpn       Date:  1990-06

6.  Radioimmunoassay and opsonic antibody responses to pneumococcal capsular polysaccharide vaccine in serum and ascitic fluid of cirrhotic patients.

Authors:  M S Simberkoff; G S Schiffman; J R Spicehandler; N H Moldover; J J Rahal
Journal:  J Clin Microbiol       Date:  1983-07       Impact factor: 5.948

7.  Increased activity of the complement system in the liver of patients with alcoholic hepatitis.

Authors:  Hong Shen; Barbara A French; Hui Liu; Brittany C Tillman; Samuel W French
Journal:  Exp Mol Pathol       Date:  2014-09-16       Impact factor: 3.362

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.